Cargando…

Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies

Glioblastoma is the most frequent primary neoplasm of the central nervous system and still suffers from very poor therapeutic impact. No clear improvements over current standard of care have been made in the last decade. For other cancers, but also for brain metastasis, which harbors a very distinct...

Descripción completa

Detalles Bibliográficos
Autores principales: Genoud, Vassilis, Migliorini, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036548/
https://www.ncbi.nlm.nih.gov/pubmed/33800593
http://dx.doi.org/10.3390/ijms22073493